Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Kufner

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Clinical Medicine|October 29, 2025
Extended Real-World Efficacy of Faricimab in Therapy-Resistant Macular Edema Due to Retinal Vein Occlusion: 9-Month Follow-Up ResultsMichael Hafner, Tina R Herold, Alexander Kufner, et al.
Diagnostics (Basel, Switzerland)|March 14, 2026
Quantitative Comparison of Two Novel Swept-Source Optical Coherence Tomography Angiography DevicesMichael Hafner, Daniel J P Deschler, Alexander Kufner, et al.
Journal of Clinical Medicine|April 12, 2025
Switching to Faricimab in Therapy-Resistant Macular Edema Due to Retinal Vein Occlusion: Initial Real-World Efficacy OutcomesMichael Hafner, Tina R Herold, Alexander Kufner, et al.
BMJ Open Ophthalmology|June 1, 2025
Deep learning-assisted analysis of biomarker changes after increase of dosing from aflibercept 2 mg to 8 mg in therapy-resistant neovascular age-related macular degenerationMichael Hafner, Ben Asani, Franziska Eckardt, et al.
European Radiology Experimental|November 4, 2024
Dark-field radiography for the detection of bone microstructure changes in osteoporotic human lumbar spine specimensJon F Rischewski, Florian T Gassert, Theresa Urban, et al.
Frontiers in Physiology|August 3, 2023
Dark-field X-ray imaging for the assessment of osteoporosis in human lumbar spine specimensFlorian T Gassert, Theresa Urban, Alexander Kufner, et al.
Biorxiv : the Preprint Server for Biology|October 4, 2023
Role Of The C-C Motif Chemokine Ligand 5 (CCL5) And Its Receptor, C-C Motif Chemokine Receptor 5 (CCR5) In The Genesis Of Aldosterone-induced Hypertension, Vascular Dysfunction, And End-organ DamageRafael M Costa, Débora M Cerqueira, Ariane Bruder-Nascimento, et al.
Quantitative Imaging in Medicine and Surgery|August 3, 2021
Vertebral bone marrow T2* mapping using chemical shift encoding-based water-fat separation in the quantitative analysis of lumbar osteoporosis and osteoporotic fracturesYannik Leonhardt, Florian T Gassert, Georg Feuerriegel, et al.
Journal of Magnetic Resonance Imaging : JMRI|July 28, 2023
Comparing CT-Like Images Based on Ultra-Short Echo Time and Gradient Echo T1-Weighted MRI Sequences for the Assessment of Vertebral Disorders Using Histology and True CT as the Reference StandardFlorian T Gassert, Alexander Kufner, Martin Renz, et al.
Hypertension (Dallas, Tex. : 1979)|January 19, 2024
Role of the CCL5 and Its Receptor, CCR5, in the Genesis of Aldosterone-Induced Hypertension, Vascular Dysfunction, and End-Organ DamageRafael M Costa, Débora M Cerqueira, Ariane Bruder-Nascimento, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Clinical Medicine|October 29, 2025
Extended Real-World Efficacy of Faricimab in Therapy-Resistant Macular Edema Due to Retinal Vein Occlusion: 9-Month Follow-Up ResultsMichael Hafner, Tina R Herold, Alexander Kufner, et al.
Diagnostics (Basel, Switzerland)|March 14, 2026
Quantitative Comparison of Two Novel Swept-Source Optical Coherence Tomography Angiography DevicesMichael Hafner, Daniel J P Deschler, Alexander Kufner, et al.
Journal of Clinical Medicine|April 12, 2025
Switching to Faricimab in Therapy-Resistant Macular Edema Due to Retinal Vein Occlusion: Initial Real-World Efficacy OutcomesMichael Hafner, Tina R Herold, Alexander Kufner, et al.
BMJ Open Ophthalmology|June 1, 2025
Deep learning-assisted analysis of biomarker changes after increase of dosing from aflibercept 2 mg to 8 mg in therapy-resistant neovascular age-related macular degenerationMichael Hafner, Ben Asani, Franziska Eckardt, et al.
European Radiology Experimental|November 4, 2024
Dark-field radiography for the detection of bone microstructure changes in osteoporotic human lumbar spine specimensJon F Rischewski, Florian T Gassert, Theresa Urban, et al.
Frontiers in Physiology|August 3, 2023
Dark-field X-ray imaging for the assessment of osteoporosis in human lumbar spine specimensFlorian T Gassert, Theresa Urban, Alexander Kufner, et al.
Biorxiv : the Preprint Server for Biology|October 4, 2023
Role Of The C-C Motif Chemokine Ligand 5 (CCL5) And Its Receptor, C-C Motif Chemokine Receptor 5 (CCR5) In The Genesis Of Aldosterone-induced Hypertension, Vascular Dysfunction, And End-organ DamageRafael M Costa, Débora M Cerqueira, Ariane Bruder-Nascimento, et al.
Quantitative Imaging in Medicine and Surgery|August 3, 2021
Vertebral bone marrow T2* mapping using chemical shift encoding-based water-fat separation in the quantitative analysis of lumbar osteoporosis and osteoporotic fracturesYannik Leonhardt, Florian T Gassert, Georg Feuerriegel, et al.
Journal of Magnetic Resonance Imaging : JMRI|July 28, 2023
Comparing CT-Like Images Based on Ultra-Short Echo Time and Gradient Echo T1-Weighted MRI Sequences for the Assessment of Vertebral Disorders Using Histology and True CT as the Reference StandardFlorian T Gassert, Alexander Kufner, Martin Renz, et al.
Hypertension (Dallas, Tex. : 1979)|January 19, 2024
Role of the CCL5 and Its Receptor, CCR5, in the Genesis of Aldosterone-Induced Hypertension, Vascular Dysfunction, and End-Organ DamageRafael M Costa, Débora M Cerqueira, Ariane Bruder-Nascimento, et al.
Pageof 1